South Africa has begun rolling out lenacapavir, a twice-yearly injectable HIV prevention drug hailed as the most significant HIV prevention breakthrough in a generation. Experts say the new option could transform protection for people who struggle with daily medication, while expanding the country’s toolkit against new infections.